Analysts expect big earnings jumps from these ASX 200 growth stocks

The international potential of these stocks is excellent.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) growth stocks can be some of the best performers over the long term. The power of compounding can really help drive earnings higher over time.

Companies that can successfully tap into the global economy can grow their profit significantly. Some ASX businesses are focused mainly on the domestic market – Australia is a great country, but it has a relatively small population.

When I look at some of the ASX's best performers over the past decade, there's certainly been a strong international aspect to their success. I'm thinking about names like Pro Medicus Ltd (ASX: PME), WiseTech Global Ltd (ASX: WTC), Altium and TechnologyOne Ltd (ASX: TNE).

I'm going to talk about two ASX 200 growth stocks that analysts think have plenty of growth potential.

A young woman's hands are shown close up with many blingy gold rings on her fingers and two large gold chains around her neck with dollar signs on them.

Image source: Getty Images

Lovisa Holdings Ltd (ASX: LOV)

Lovisa is a retailer that sells affordable jewellery to younger shoppers in Australia and multiple other countries.

At the end of the FY24 first half, it had at least 10 stores in markets like Australia (175 stores), New Zealand (27), Singapore (15), Malaysia (43), South Africa (77), the UK (47), France (80), Germany (51), Belgium (13), Poland (19), the USA (2017) and Canada (10).

In the six months to 31 December 2023, the ASX 200 growth stock added 53 net new stores. Adding more stores globally can provide the foundation for strong earnings growth in FY25 and beyond.

The broker UBS has predicted that Lovisa could generate $81 million of net profit after tax (NPAT) in FY24, which could be year over year growth of 19%. Lovisa is then predicted to deliver 31% profit growth to $106 million in FY25.

The broker predicts Lovisa could achieve NPAT of $172 million by FY28, which would represent growth of more than 100% compared to FY24.

The Lovisa share price is valued at 21x FY28's estimated earnings.

Xero Ltd (ASX: XRO)

Xero is one of the world's leading cloud accounting software businesses. It helps accountants and business owners save time with various automation tools, can help with various business operations, and presents information in a very understandable way.

The ASX 200 growth stock is doing really well at growing subscribers around the world, particularly in its key markets of the UK and Australia.

In the FY24 result, the business delivered total subscriber growth of 11% to 4.16 million, average revenue per user (ARPU) growth to $39.29 and operating revenue jumped 22% to $1.7 billion. Adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) soared 75% to $526.5 million and it made $174.6 million of net profit.

Xero recently decided to increase prices for its Australian and UK subscribers, which could help accelerate profit in the coming years.

UBS suggests Xero's net profit could jump 37% to $240 million. The broker forecasts the ASX 200 growth stock could reach a net profit of $987 million in FY29, which would be growth of 464% compared to FY24.

Motley Fool contributor Tristan Harrison has positions in Lovisa. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa, Pro Medicus, Technology One, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Lovisa, Pro Medicus, and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Growth Shares

3 ASX 200 shares down over 30% that I'd buy

The market has turned cautious on these shares, but I still see long-term growth potential.

Read more »

A stopwatch ticking close to the 12 where the words on the face say 'Time to Buy'.
Growth Shares

2 top ASX shares to buy and hold for the next decade

I’d own these businesses for the next decade or more…

Read more »

Buy and sell written on a white cube.
Growth Shares

Experts say these ASX 200 shares have great potential

These stocks could be underrated buys, according to this fund manager.

Read more »

A smiling woman with a handful of $100 notes, indicating strong dividend payments
Growth Shares

Where to invest $10,000 in ASX 200 shares in July

These shares offer quality and bags of growth. Here's what you need to know.

Read more »

Researchers and doctors with futuristic 3D hologram overlay for body anatomy or DNA in hospital clinic.
Growth Shares

This ASX growth stock is up 500% this year and set to keep rising 

This is one of the hottest ASX growth stocks right now.

Read more »

Rising arrow on a blue graph symbolising a rising share price.
Growth Shares

Where I'd invest $20,000 into ASX growth shares right now

These investments have the ability to deliver great returns.

Read more »

Five happy friends on their phones.
Growth Shares

10 fantastic ASX shares to buy for FY27

Looking for investment ideas? Check out these names.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Growth Shares

3 ASX 200 shares I'd buy and hold for life

Want to buy and hold for life? Here are three shares that could be worth considering.

Read more »